Reetobrata Basu Selected Research

Reetobrata Basu Research Topics

10	Neoplasms (Cancer) 01/2022 - 01/2017
4	Melanoma (Melanoma, Malignant) 12/2020 - 01/2017
2	Insulin Resistance 12/2021 - 01/2020
2	Acromegaly 01/2021 - 11/2020
2	Tuberculosis (Tuberculoses) 02/2015 - 01/2014
1	Cognitive Dysfunction 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Chagas Disease (American Trypanosomiasis) 01/2022
1	Growth Disorders 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2014

8	Growth Hormone (Somatotropin)IBA 01/2022 - 03/2017
5	Pharmaceutical PreparationsIBA 12/2020 - 01/2014
3	Somatotropin Receptors (Growth Hormone Receptor)IBA 12/2021 - 01/2017
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 01/2020
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2019 - 01/2017
2	Small Interfering RNA (siRNA)IBA 03/2017 - 01/2017
2	DNA GyraseIBA 02/2015 - 01/2014
2	Adenosine Triphosphatases (ATPase)IBA 02/2015 - 01/2014
1	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2021
1	Insulin-Like PeptidesIBA 12/2020
1	bovine growth hormoneIBA 11/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 09/2019
1	Messenger RNA (mRNA)IBA 03/2017
1	Carrier Proteins (Binding Protein)IBA 03/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	XenobioticsIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	VemurafenibIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	oridoninIBA 01/2017
1	Moxifloxacin (Avelox)FDA Link 01/2014
1	EnzymesIBA 01/2014

4	Therapeutics 01/2020 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2017